Cargando…

Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals

Pharmaceutical research can be structured into clear national strategies that optimize patient health and foster innovation. The objectives of this document are to assess the need for a national pharmaceutical research strategy based on the current situation in Lebanon, to identify the strengths and...

Descripción completa

Detalles Bibliográficos
Autores principales: Akel, Marwan, Hajj, Aline, Sacre, Hala, Zeenny, Rony M., Haddad, Chadia, Salameh, Pascale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672651/
https://www.ncbi.nlm.nih.gov/pubmed/36397120
http://dx.doi.org/10.1186/s40545-022-00485-1
_version_ 1784832784591749120
author Akel, Marwan
Hajj, Aline
Sacre, Hala
Zeenny, Rony M.
Haddad, Chadia
Salameh, Pascale
author_facet Akel, Marwan
Hajj, Aline
Sacre, Hala
Zeenny, Rony M.
Haddad, Chadia
Salameh, Pascale
author_sort Akel, Marwan
collection PubMed
description Pharmaceutical research can be structured into clear national strategies that optimize patient health and foster innovation. The objectives of this document are to assess the need for a national pharmaceutical research strategy based on the current situation in Lebanon, to identify the strengths and weaknesses of pharmaceutical research in Lebanon, and to suggest a pharmaceutical research strategy for Lebanon, including goals and objectives. In Lebanon, in the absence of a national health research policy, pharmaceutical research is conducted in academia or hospitals, although projects are the result of personal or team initiatives that should be organized to better serve the needs of the country. Many strengths of pharmaceutical research were identified, such as the pharmaceutical workforce and academics who are willing to contribute to research, while the implementation of the national pharmaceutical strategy represents an important opportunity to promote research. Among the weaknesses is the lack of research culture in some institutions and interinstitutional/interprofessional collaborations. Thus, the suggested strategy aims to structure pharmaceutical research in Lebanon, including the priorities towards which research is directed, the process by which research is conducted, and the workforce conducting research. It will mainly rely on the World Health Organization's interrelated goals (organization, priorities, capacity, standards, and translation). The implementation of the suggested pharmaceutical research strategy will only be achieved through the leadership of the pharmaceutical authorities and the collaboration of stakeholders.
format Online
Article
Text
id pubmed-9672651
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96726512022-11-18 Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals Akel, Marwan Hajj, Aline Sacre, Hala Zeenny, Rony M. Haddad, Chadia Salameh, Pascale J Pharm Policy Pract Commentary Pharmaceutical research can be structured into clear national strategies that optimize patient health and foster innovation. The objectives of this document are to assess the need for a national pharmaceutical research strategy based on the current situation in Lebanon, to identify the strengths and weaknesses of pharmaceutical research in Lebanon, and to suggest a pharmaceutical research strategy for Lebanon, including goals and objectives. In Lebanon, in the absence of a national health research policy, pharmaceutical research is conducted in academia or hospitals, although projects are the result of personal or team initiatives that should be organized to better serve the needs of the country. Many strengths of pharmaceutical research were identified, such as the pharmaceutical workforce and academics who are willing to contribute to research, while the implementation of the national pharmaceutical strategy represents an important opportunity to promote research. Among the weaknesses is the lack of research culture in some institutions and interinstitutional/interprofessional collaborations. Thus, the suggested strategy aims to structure pharmaceutical research in Lebanon, including the priorities towards which research is directed, the process by which research is conducted, and the workforce conducting research. It will mainly rely on the World Health Organization's interrelated goals (organization, priorities, capacity, standards, and translation). The implementation of the suggested pharmaceutical research strategy will only be achieved through the leadership of the pharmaceutical authorities and the collaboration of stakeholders. BioMed Central 2022-11-17 /pmc/articles/PMC9672651/ /pubmed/36397120 http://dx.doi.org/10.1186/s40545-022-00485-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Commentary
Akel, Marwan
Hajj, Aline
Sacre, Hala
Zeenny, Rony M.
Haddad, Chadia
Salameh, Pascale
Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals
title Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals
title_full Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals
title_fullStr Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals
title_full_unstemmed Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals
title_short Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals
title_sort developing a national pharmaceutical research strategy in lebanon: opportunities to bridge the gaps and reach the goals
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672651/
https://www.ncbi.nlm.nih.gov/pubmed/36397120
http://dx.doi.org/10.1186/s40545-022-00485-1
work_keys_str_mv AT akelmarwan developinganationalpharmaceuticalresearchstrategyinlebanonopportunitiestobridgethegapsandreachthegoals
AT hajjaline developinganationalpharmaceuticalresearchstrategyinlebanonopportunitiestobridgethegapsandreachthegoals
AT sacrehala developinganationalpharmaceuticalresearchstrategyinlebanonopportunitiestobridgethegapsandreachthegoals
AT zeennyronym developinganationalpharmaceuticalresearchstrategyinlebanonopportunitiestobridgethegapsandreachthegoals
AT haddadchadia developinganationalpharmaceuticalresearchstrategyinlebanonopportunitiestobridgethegapsandreachthegoals
AT salamehpascale developinganationalpharmaceuticalresearchstrategyinlebanonopportunitiestobridgethegapsandreachthegoals